「pr」の検索結果
234件：171～175件目を表示
-
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeLaunched（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye...
http://www.senju.co.jp/english/rd/pipeline.html -
お知らせ | 千寿製薬株式会社
https://www.senju.co.jp/english/news/javascipt: void(0); -
お知らせ | 千寿製薬株式会社
June 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（...
http://www.senju.co.jp/english/news/ -
Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical
ra through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fields.Senju Pharmaceutical Co., Ltd. will start the medical device business ane...
https://www.senju.co.jp/english/about/business/device.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
orado, United States of America Formulation study of a steroid-timolol fixed-combination ophthalmic preparation to optimize intraocular penetration 豊田 彩貴、澤 嗣郎、吉松 歩美、吹上 知穂、大鳥 聡 ARVO 2026 開催日：2026年5月３日～...
http://www.senju.co.jp/english/rd/society/